NCT05835479 - Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions

Pneumocystis Pneumonia

Interventions

DRUG

Co-Trimoxazole

Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication

DRUG

Rezafungin Acetate / Co Trimoxazole

"Rezafungin for infusion. Intravenous anti fungal therapy~Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication"

Trial Locations (6)

Unknown

RECRUITING

University of Cape Town, Cape Town

RECRUITING

Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg

TERMINATED

Helen Joseph Hospital, Johannesburg

RECRUITING

Global Clinical Trials - Pretoria, Pretoria

RECRUITING

Steve Biko Academic Hospital, Pretoria

RECRUITING

Netcare Umhlanga Medical Centre, Umhlanga

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY